Finding treatments for advanced multiple sclerosis (MS) has been difficult. But new research may help neurologists identify which drugs are…

Home »
Finding treatments for advanced multiple sclerosis (MS) has been difficult. But new research may help neurologists identify which drugs are…
PARIS, March 31, 2021 /PRNewswire/ — The U.S. Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) in combination with…
Many COVID-19 “long haulers” experience at least four lingering neurological symptoms, such as brain fog, headache and the loss of…
People with multiple sclerosis (MS) may not be at higher risk of developing two of the three cancers that occur…
A group of researchers, including personnel from the University of Granada (UGR), has recently presented the results of a study…
A new study led by Queen Mary University of London has demonstrated the effectiveness of using a novel light technology…
In a bid to determine factors linked to the most debilitating forms of multiple sclerosis (MS), Johns Hopkins Medicine researchers…
A new woman! The Bachelor alum Vienna Girardi showed off the results of her multiple plastic surgeries in new photos…
(HealthDay)—Individuals with low- or intermediate-risk monoclonal gammopathy of undetermined significance (MGUS) can experience progression to multiple myeloma within five years,…
A new study has shown that people in the advanced stage of multiple sclerosis (MS) experience significant improvements in movement…